Bisoprolol Fumarate And Hydrochlorothiazide


Bisoprolol Fumarate And Hydrochlorothiazide

Drug - Bisoprolol Fumarate And Hydrochlorothiazide
The trade name of the product as shown on the labeling.

The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Bisoprolol Fumarate; Hydrochlorothiazide
Multiple ingredients are in alphabetical order.

Strength - 10MG;6.25MG
The potency of the active ingredient(s), Bisoprolol Fumarate; Hydrochlorothiazide. May repeat for multiple part products.

Applicant - WATSON LABS
The firm name holding legal responsibility for Bisoprolol Fumarate And Hydrochlorothiazide. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 075469
The FDA assigned number to Bisoprolol Fumarate And Hydrochlorothiazide. Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Bisoprolol Fumarate And Hydrochlorothiazide. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 25, 2000
The date Bisoprolol Fumarate And Hydrochlorothiazide was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Bisoprolol Fumarate And Hydrochlorothiazide. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Bisoprolol Fumarate And Hydrochlorothiazide is in. Format is RX, OTC, DISCN.

Applicant Full Name - Watson Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Bisoprolol Fumarate And Hydrochlorothiazide.

Bisoprolol Fumarate And Hydrochlorothiazide